These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 6177404)

  • 1. Use of aminoglutethimide as second-line endocrine therapy in metastatic breast cancer.
    Kaye SB; Woods RL; Fox RM; Coates AS; Tattersall MH
    Cancer Res; 1982 Aug; 42(8 Suppl):3445s-3447s. PubMed ID: 6177404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamoxifen versus aminoglutethimide versus combined tamoxifen and aminoglutethimide in the treatment of advanced breast carcinoma.
    Smith IE; Harris AL; Morgan M; Gazet JC; McKinna JA
    Cancer Res; 1982 Aug; 42(8 Suppl):3430s-3433s. PubMed ID: 7044525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminoglutethimide in the treatment of advanced postmenopausal breast cancer.
    Harris AL; Powles TJ; Smith IE
    Cancer Res; 1982 Aug; 42(8 Suppl):3405s-3408s. PubMed ID: 7083207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminoglutethimide as second line endocrine therapy in advanced breast cancer.
    Brufman G; Biran S
    Anticancer Res; 1986; 6(5):1065-8. PubMed ID: 3800315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of metastatic breast cancer with aminoglutethimide after progression on chemotherapy and/or hormonal therapy with tamoxifen.
    Brufman G; Biran S
    Eur J Surg Oncol; 1985 Mar; 11(1):27-31. PubMed ID: 2985452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminoglutethimide after tamoxifen therapy in advanced breast cancer: M. D. Anderson Hospital experience.
    Buzdar AU; Powell KC; Blumenschein GR
    Cancer Res; 1982 Aug; 42(8 Suppl):3448s-3450s. PubMed ID: 7083209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminoglutethimide in the treatment of metastatic breast cancer.
    Troner MB
    Cancer Res; 1982 Aug; 42(8 Suppl):3402s-3404s. PubMed ID: 7083206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer.
    Lipton A; Harvey HA; Santen RJ; Boucher A; White D; Bernath A; Dixon R; Richards G; Shafik A
    Cancer Res; 1982 Aug; 42(8 Suppl):3434s-3436s. PubMed ID: 7044526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress report on two clinical trials in women with advanced breast cancer. Trial I: tamoxifen versus tamoxifen plus aminoglutethimide. Trial II: aminoglutethimide in patients with prior tamoxifen exposure.
    Ingle JN; Green SJ; Ahmann DL; Edmonson JH; Nichols WC; Frytak S; Rubin J
    Cancer Res; 1982 Aug; 42(8 Suppl):3461s-3467s. PubMed ID: 7044529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-over comparison of tamoxifen and aminoglutethimide in advanced breast cancer.
    Harvey HA; Lipton A; White DS; Santen RJ; Boucher AE; Shafik AS; Dixon RJ
    Cancer Res; 1982 Aug; 42(8 Suppl):3451s-3453s. PubMed ID: 6177405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic use of tamoxifen in advanced breast cancer: correlation with biochemical parameters.
    Morgan LR; Schein PS; Woolley PV; Hoth D; Macdonald J; Lippman M; Posey LE; Beazley RW
    Cancer Treat Rep; 1976 Oct; 60(10):1437-43. PubMed ID: 191185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aminoglutethimide and aminoglutethimide+tamoxifen treatment for advanced breast cancer].
    Hisamatsu K; Nomura Y; Tashiro H
    Gan To Kagaku Ryoho; 1992 Oct; 19(12):2017-23. PubMed ID: 1417009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminoglutethimide as second line therapy in advanced breast cancer.
    Elomaa I; Blomqvist C; Rissanen P
    Breast Cancer Res Treat; 1986; 7 Suppl():S51-4. PubMed ID: 3017481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of hormone therapy with aminoglutethimide (Rodazol) in postmenopausal metastatic breast cancer].
    Schmidt UM; Brockmann B; Geschke E
    Geburtshilfe Frauenheilkd; 1991 Apr; 51(4):276-9. PubMed ID: 1713564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminoglutethimide in tamoxifen-resistant patients: The Melbourne Experience.
    Murray RM; Pitt P
    Cancer Res; 1982 Aug; 42(8 Suppl):3437s-3441s. PubMed ID: 6211229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminoglutethimide without hydrocortisone in the treatment of postmenopausal patients with advanced breast cancer.
    Höffken K; Kempf H; Miller AA; Miller B; Schmidt CG; Faber P; Kley HK
    Cancer Treat Rep; 1986 Oct; 70(10):1153-7. PubMed ID: 3756937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [2d and 3d line hormonal therapy in postmenopausal metastatic breast tumor. Comparison of medroxyprogesterone acetate and aminoglutethimide in tamoxifen-resistant patients].
    Garcia-Giralt E; Omodei Zorini C; Ferri L; Ayme Y; Carton M; Daban A; Delozier T; Fargeot P; Fumoleau P; Gorins A
    Clin Ter; 1994 Aug; 145(8):113-21. PubMed ID: 7955956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors affecting response to aminoglutethimide in advanced breast cancer.
    Brufman G
    Anticancer Res; 1993; 13(4):1235-7. PubMed ID: 8352549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Aminoglutethimide therapy in advanced breast cancer].
    Kühböck J; Ludwig H; Pötzi P; Zielinski C
    Wien Med Wochenschr; 1985 Dec; 135(23-24):608-11. PubMed ID: 4096007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment of metastatic breast cancer with aminoglutethimide.
    Kaye SB; Woods RL; Fox RM; Tattersall MH
    Aust N Z J Med; 1981 Aug; 11(4):370-4. PubMed ID: 7030292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.